Could a soy supplement in baby food ward off asthma?

NCT ID NCT05667701

Recruiting now Prevention Sponsor: Rajesh Kumar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving a soy isoflavone supplement to infants at high risk for asthma can reduce their chance of developing the condition. Researchers will give 65 babies either the supplement or a placebo twice daily for 7 months, tracking wheezing episodes and immune markers. The goal is to see if this simple dietary addition can shift the immune response away from an asthma-prone pattern.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: soy isoflavone supplement (Novasoy)
What this could lead to: If it works, this could point toward a simple dietary supplement to help prevent asthma in high-risk infants.
What could go wrong: This is a small, early-phase trial (65 infants) focused on biological markers, not yet proven to prevent wheezing or asthma. Results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA IN CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood onset asthma Respiratory Sounds asthma prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA IN CHILDREN WHEEZING

Contacts and locations

Locations

Ann and Robert H Lurie Childrens Hospital of Chicago
RECRUITING

Chicago, Illinois, 60611, United States
Northwestern University Feinberg School of Medicine
RECRUITING

Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.